PHAS David James Ballance bought PhaseBio Pharmaceuticals Inc shares — SEC Form 4BUYPhaseBio Pharmaceuticals Inc

David James Ballance, VP, Research and Sci. Affairs at PhaseBio Pharmaceuticals Inc (PHAS), bought 1,000 shares at $3.94 ($4K) on 2018-12-13, disclosed to the SEC on 2018-12-17.

SEC EDGAR Filing

0001209191-18-062939

View on SEC EDGAR

Trade context

Open-market purchase of $4k PHAS by VP, Research and Sci. Affairs. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).

Strong70/100

Clearly above the average filing.

First-Time BuyerBuying the DipOpportunistic Buy

Filing Info

Filed2018-12-17

Traded2018-12-13

Accession0001209191-18-062939

Sourcesec_form345

Insider

NameDavid James Ballance

TitleVP, Research and Sci. Affairs

PIT GradeInsiderUnrated

View Company View Insider

Get an email when an insider at PHAS files

Free account. Follow PHAS and up to 10 more companies.

Follow PHAS for free

PHAS David James Ballance bought PhaseBio Pharmaceuticals Inc shares — SEC Form 4BUYPhaseBio Pharmaceuticals Inc

Filing Info

Insider

Trade Details

Outcomes